Literature DB >> 25330398

Mechanism of amyloid-β fibril elongation.

Thomas Gurry1, Collin M Stultz.   

Abstract

Amyloid-β is an intrinsically disordered protein that forms fibrils in the brains of patients with Alzheimer's disease. To explore factors that affect the process of fibril growth, we computed the free energy associated with disordered amyloid-β monomers being added to growing amyloid fibrils using extensive molecular dynamics simulations coupled with umbrella sampling. We find that the mechanisms of Aβ40 and Aβ42 fibril elongation have many features in common, including the formation of an obligate on-pathway β-hairpin intermediate that hydrogen bonds to the fibril core. In addition, our data lead to new hypotheses for how fibrils may serve as secondary nucleation sites that can catalyze the formation of soluble oligomers, a finding in agreement with recent experimental observations. These data provide a detailed mechanistic description of amyloid-β fibril elongation and a structural link between the disordered free monomer and the growth of amyloid fibrils and soluble oligomers.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25330398     DOI: 10.1021/bi500695g

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  28 in total

1.  N-Terminal Modified Aβ Variants Enable Modulations to the Structures and Cytotoxicity Levels of Wild-Type Aβ Fibrils through Cross-Seeding.

Authors:  Zhi-Wen Hu; Dan Fai Au; Letticia Cruceta; Liliya Vugmeyster; Wei Qiang
Journal:  ACS Chem Neurosci       Date:  2020-07-06       Impact factor: 4.418

2.  Proteolysis of truncated hemolysin A yields a stable dimerization interface.

Authors:  Walter R P Novak; Basudeb Bhattacharyya; Daniel P Grilley; Todd M Weaver
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2017-02-21       Impact factor: 1.056

3.  Elongation affinity, activation barrier, and stability of Aβ42 oligomers/fibrils in physiological saline.

Authors:  Roberto A Rodriguez; Liao Y Chen; Germán Plascencia-Villa; George Perry
Journal:  Biochem Biophys Res Commun       Date:  2017-04-17       Impact factor: 3.575

4.  Zinc as chaperone-mimicking agent for retardation of amyloid β peptide fibril formation.

Authors:  Axel Abelein; Astrid Gräslund; Jens Danielsson
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-30       Impact factor: 11.205

5.  Elucidating Important Sites and the Mechanism for Amyloid Fibril Formation by Coarse-Grained Molecular Dynamics.

Authors:  Ana Rojas; Nika Maisuradze; Khatuna Kachlishvili; Harold A Scheraga; Gia G Maisuradze
Journal:  ACS Chem Neurosci       Date:  2016-11-18       Impact factor: 4.418

6.  On the lack of polymorphism in Aβ-peptide aggregates derived from patient brains.

Authors:  Erik J Alred; Malachi Phillips; Workalemahu M Berhanu; Ulrich H E Hansmann
Journal:  Protein Sci       Date:  2015-04-14       Impact factor: 6.725

7.  Probing transient non-native states in amyloid beta fiber elongation by NMR.

Authors:  Jeffrey R Brender; Anirban Ghosh; Samuel A Kotler; Janarthanan Krishnamoorthy; Swapna Bera; Vanessa Morris; Timir Baran Sil; Kanchan Garai; Bernd Reif; Anirban Bhunia; Ayyalusamy Ramamoorthy
Journal:  Chem Commun (Camb)       Date:  2019-04-11       Impact factor: 6.222

8.  Frustrated peptide chains at the fibril tip control the kinetics of growth of amyloid-β fibrils.

Authors:  Yuechuan Xu; Kaitlin Knapp; Kyle N Le; Nicholas P Schafer; Mohammad S Safari; Aram Davtyan; Peter G Wolynes; Peter G Vekilov
Journal:  Proc Natl Acad Sci U S A       Date:  2021-09-21       Impact factor: 11.205

9.  Amyloid Fibril Design: Limiting Structural Polymorphism in Alzheimer's Aβ Protofilaments.

Authors:  Bartłomiej Tywoniuk; Ye Yuan; Sarah McCartan; Beata Maria Szydłowska; Florentina Tofoleanu; Bernard R Brooks; Nicolae-Viorel Buchete
Journal:  J Phys Chem B       Date:  2018-11-29       Impact factor: 2.991

Review 10.  Amyloid Oligomers: A Joint Experimental/Computational Perspective on Alzheimer's Disease, Parkinson's Disease, Type II Diabetes, and Amyotrophic Lateral Sclerosis.

Authors:  Phuong H Nguyen; Ayyalusamy Ramamoorthy; Bikash R Sahoo; Jie Zheng; Peter Faller; John E Straub; Laura Dominguez; Joan-Emma Shea; Nikolay V Dokholyan; Alfonso De Simone; Buyong Ma; Ruth Nussinov; Saeed Najafi; Son Tung Ngo; Antoine Loquet; Mara Chiricotto; Pritam Ganguly; James McCarty; Mai Suan Li; Carol Hall; Yiming Wang; Yifat Miller; Simone Melchionna; Birgit Habenstein; Stepan Timr; Jiaxing Chen; Brianna Hnath; Birgit Strodel; Rakez Kayed; Sylvain Lesné; Guanghong Wei; Fabio Sterpone; Andrew J Doig; Philippe Derreumaux
Journal:  Chem Rev       Date:  2021-02-05       Impact factor: 60.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.